Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia - Commentary

Ricardo J. Komotar, E. Sander Connolly

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalNeurosurgery
Volume61
Issue number3
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this